← Back to Search

Learning Strategies for Autism

Q: How many individuals have been incorporated into this research project?

Affirmative. According to clinicaltrials.gov, this medical experiment first went public on August 1st 2022 and has been revised most recently as of November 11th 2022. 200 patients will be recruited from two separate sites for the trial's duration.

Q: Does this clinical trial have an age restriction and if so, what is it?

This clinical trial stipulates that the lower bound for patient age is 24 months and the upper limit of enrolment eligibility is 71 months.

Q: Does my profile satisfy the requirements to join this research effort?

The study requires 200 participants between 24 and 71 months of age who have been diagnosed with <a href="https://www.withpower.com/clinical-trials/autism">Autism</a> Spectrum Disorder. Additional inclusion criteria involves a minimum language and nonverbal cognition age of at least two years old.

N/A

Waitlist Available

Research Sponsored by New York University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during test phase of the experimental session (e.g., within 5 seconds)

Awards & highlights

Study Summary

This trial is testing whether children with ASD can learn new words by overhearing conversations.

Who is the study for?

This study is for children aged 24 to 71 months who either have Autism Spectrum Disorder or are typically developing. They must have a minimum language and nonverbal cognition age of 24 months, speak English as their native language, and not be born prematurely (<36 weeks). Children with uncorrected hearing or vision issues, photosensitive epilepsy, or other cognitive-impacting conditions besides ASD (except ADHD) cannot participate.Check my eligibility

What is being tested?

The trial investigates if children with ASD can learn verbs and pronouns from overheard conversations compared to typically developing children. It aims to understand how these kids process words that aren't just object labels when they're not directly involved in the conversation.See study design

What are the potential side effects?

Since this study involves observational learning without medical interventions, there are no direct side effects associated with drugs or treatments. However, participation may involve typical risks of psychological research such as discomfort from sitting still during sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during test phase of the experimental session (e.g., within 5 seconds)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during test phase of the experimental session (e.g., within 5 seconds)

This trial's timeline: 3 weeks for screening, Varies for treatment, and during test phase of the experimental session (e.g., within 5 seconds) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Object selection

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: OverheardExperimental Treatment1 Intervention

Children are present in the room while an experimenter uses the word to be learned in an interaction with another experimenter.

Group II: AddressedActive Control1 Intervention

Children participate in an interaction with an experimenter who uses the word to be learned.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor

226 Previous Clinical Trials

314,076 Total Patients Enrolled

3 Trials studying Autism Spectrum Disorder

1,450 Patients Enrolled for Autism Spectrum Disorder

Emerson CollegeOTHER

3 Previous Clinical Trials

537 Total Patients Enrolled

2 Trials studying Autism Spectrum Disorder

450 Patients Enrolled for Autism Spectrum Disorder

Media Library

Addressed Speech Clinical Trial Eligibility Overview. Trial Name: NCT05193500 — N/A

Autism Spectrum Disorder Research Study Groups: Overheard, Addressed

Autism Spectrum Disorder Clinical Trial 2023: Addressed Speech Highlights & Side Effects. Trial Name: NCT05193500 — N/A

Addressed Speech 2023 Treatment Timeline for Medical Study. Trial Name: NCT05193500 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been incorporated into this research project?

"Affirmative. According to clinicaltrials.gov, this medical experiment first went public on August 1st 2022 and has been revised most recently as of November 11th 2022. 200 patients will be recruited from two separate sites for the trial's duration."

Answered by AI

Does this clinical trial have an age restriction and if so, what is it?

"This clinical trial stipulates that the lower bound for patient age is 24 months and the upper limit of enrolment eligibility is 71 months."

Answered by AI

Does my profile satisfy the requirements to join this research effort?

"The study requires 200 participants between 24 and 71 months of age who have been diagnosed with Autism Spectrum Disorder. Additional inclusion criteria involves a minimum language and nonverbal cognition age of at least two years old."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study 3 Learning Verbs and Pronouns

2022. "Study 3 Learning Verbs and Pronouns". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05193500.

All > Asd > Autism